Published on
Delving into the world of the extremely small, CHOP researchers are exploring how nanoparticles can precisely deliver anticancer drugs to attack neuroblastoma.
Published on
The history of our understanding and approach to cancer are at the center of CANCER: THE EMPEROR OF ALL MALADIES. The documentary will air in three parts on March 30, 31 and April 1 at 9 p.m. ET on PBS, with the final chapter featuring CHOP.
Published on
The FDA approved Unituxin™ (dinutuximab), which is just the third drug in history to receive initial approval for treatment of pediatric cancer. It is the first immunotherapy drug for children with cancer.
Published on
CHOP and Penn Medicine experts are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations, setting the stage for a phase 3 clinical trial.
Published on
Cancer Patient Gracie West inspires in her role as a Four Seasons Parkway Run & Walk ambassador.
Published on
The Advances in Neuroblastoma Research Association is conferring its highest honor on CHOP oncologist Garrett Brodeur, MD, for his scientific achievements.
Published on
Proton therapy for a 3-year-old with neuroblastoma compared to X-ray therapy allowed a 100-fold reduction in radiation dose to the liver, lungs, and heart.